Search Results - "Tufveson, G"

Positron Emission Tomography in Clinical Islet Transplantation by Eriksson, O., Eich, T., Sundin, A., Tibell, A., Tufveson, G., Andersson, H., Felldin, M., Foss, A., Kyllönen, L., Langstrom, B., Nilsson, B., Korsgren, O., Lundgren, T.

“…The fate of islets in clinical transplantation is unclear. To elude on this positron emission tomography combined with computed tomography (PET/CT) was…”
Get full text

Targeting CXCR1/2 Does Not Improve Insulin Secretion After Pancreatic Islet Transplantation: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Type 1 Diabetes by Maffi, Paola, Lundgren, Torbjörn, Tufveson, Gunnar, Rafael, Ehab, Shaw, James A M, Liew, Aaron, Saudek, Frantisek, Witkowski, Piotr, Golab, Karolina, Bertuzzi, Federico, Gustafsson, Bengt, Daffonchio, Luisa, Ruffini, Pier Adelchi, Piemonti, Lorenzo

“…Reparixin is an inhibitor of CXCR1/2 chemokine receptor shown to be an effective anti-inflammatory adjuvant in a pilot clinical trial in allotransplant…”
Get full text

Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation by Moberg, L, Johansson, H, Lukinius, A, Berne, C, Foss, A, Källen, R, Østraat, Ø, Salmela, K, Tibell, A, Tufveson, G, Elgue, G, Ekdahl, K Nilsson, Korsgren, O, Nilsson, B

“…Intraportal transplantation of pancreatic islets offers improved glycaemic control and insulin independence in type 1 diabetes mellitus, but intraportal…”
Get full text

Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma by Ingvar, Åsa, Smedby, Karin Ekström, Lindelöf, Bernt, Fernberg, Pia, Bellocco, Rino, Tufveson, Gunnar, Höglund, Petter, Adami, Johanna

“…Background. The risk of cutaneous squamous cell carcinoma (CSCC) is found to be substantially increased after organ transplantation. The association with…”
Get full text

Optimising islet engraftment is critical for successful clinical islet transplantation by Korsgren, O, Lundgren, T, Felldin, M, Foss, A, Isaksson, B, Permert, J, Persson, N H, Rafael, E, Rydén, M, Salmela, K, Tibell, A, Tufveson, G, Nilsson, B

“…Clinical islet transplantation is currently being explored as a treatment for persons with type 1 diabetes and hypoglycaemia unawareness. Although…”
Get full text

Calcium: A Crucial Potentiator for Efficient Enzyme Digestion of the Human Pancreas by Eich, Torsten, Ståhle, Magnus, Gustafsson, Bengt, Horneland, Rune, Lempinen, Marko, Lundgren, Torbjörn, Rafael, Ehab, Tufveson, Gunnar, Zur-Mühlen, Bengt von, Olerud, Johan, Scholz, Hanne, Korsgren, Olle

“…Background: Effective digestive enzymes are crucial for successful islet isolation. Supplemental proteases are essential because they synergize with…”
Get full text

Time Trends in Risk and Risk Determinants of Non‐Hodgkin Lymphoma in Solid Organ Transplant Recipients by Fernberg, P., Edgren, G., Adami, J., Ingvar, Å., Bellocco, R., Tufveson, G., Höglund, P., Kinch, A., Simard, J. F., Baecklund, E., Lindelöf, B., Pawitan, Y., Smedby, K. E.

“…Organ transplantation increases risk of non‐Hodgkin lymphoma (NHL), but long‐term risk and time trends have seldom been evaluated. Immunosuppressive drug load…”
Get full text

Current status of clinical islet transplantation by Korsgren, Olle, Nilsson, B, Berne, C, Felldin, M, Foss, A, Kallen, R, Lundgren, T, Salmela, K, Tibell, A, Tufveson, G

“…Islet transplantation is currently being explored as a treatment for patients with type 1 diabetes. At present, the number of patients becoming…”
Get full text

Obtaining regulatory T cells from uraemic patients awaiting kidney transplantation for use in clinical trials by Berglund, D., Karlsson, M., Biglarnia, A.‐R., Lorant, T., Tufveson, G., Korsgren, O., Carlsson, B.

“…Summary Adoptive transfer of regulatory T cells (Tregs) has been proposed for use as a cellular therapy to induce transplantation tolerance. Preclinical data…”
Get full text

Large-scale comparison of Liberase HI and collagenase NB1 utilized for human islet isolation by Brandhorst, H, Friberg, A, Nilsson, B, Andersson, H H, Felldin, M, Foss, A, Salmela, K, Tibell, A, Tufveson, G, Korsgren, O, Brandhorst, D

“…For more than a decade Liberase HI was commonly used as the standard enzyme blend for clinical human islet isolation until enforced replacement by collagenase…”
Get full text

Initial Experience With Hypothermic Machine Perfusion of Kidneys From Deceased Donors in the Uppsala Region in Sweden by Sedigh, A, Tufveson, G, Bäckman, L, Biglarnia, A.-R, Lorant, T

“…Abstract Background Simple cold storage (CS) is the gold standard for organ preservation. Recently, evidence has been presented suggesting compared with CS…”
Get full text

Efficacy and Safety of Continuous Local Infusion of Ropivacaine after Retroperitoneoscopic Live Donor Nephrectomy by Biglarnia, A.‐R., Tufveson, G., Lorant, T., Lennmyr, F., Wadström, J.

“…Morphine‐based analgesia is effective but can compromise donor safety. We investigated whether continuous infusion of local anesthetics (CILA) can provide…”
Get full text

Mycophenolate mofetil in renal transplantation : 3-year results from the placebo-controlled trial by Vanrenterghem, Y

“…The European double-blind, placebo-(PLA) controlled study of mycophenolate mofetil (MMF) for prevention of acute renal allograft rejection showed that MMF 2…”
Get full text

Is Rituximab Safe to Use in Kidney Transplant Patients? by Tydén, G., Mjornstedt, L., Ekberg, H., Tufveson, G.

Get full text

Hyaluronidase Treatment of Graft Pancreatitis in Rats: Marked Effects on the Blood Perfusion of the Transplanted Pancreas by Jansson, L, Tufveson, G, Bodin, B, Emanuelsson, C

“…Hyaluronan is known to accumulate in tissues during inflammatory diseases associated with graft implantation and rejection of organ allografts. The aim was to…”
Get full text

Factors Influencing Outcome of Simultaneous Kidney and Pancreas Transplantation: A 23-year Single-Center Clinical Experience by Yamamoto, S, Tufveson, G, Wahlberg, J, Berne, C, Wadström, J, Biglarnia, A.R

“…Abstract Introduction Simultaneous kidney and pancreas transplantation (SKPT) has become an effective treatment for patients who have diabetes mellitus type I…”
Get full text

The ethics of non-heart-beating donation: how new technology can change the ethical landscape by Zeiler, K, Furberg, E, Tufveson, G, Welin, S

“…The global shortage of organs for transplantation and the development of new and better medical technologies for organ preservation have resulted in a renewed…”
Get full text

Effects of commonly used immunosuppressants on graft‐derived fibroblasts by JOHNSSON, C., GERDIN, B., TUFVESON, G.

“…SUMMARY In acute rejection of transplanted organs intragraft fibroblasts increase their production of hyaluronan. Hyaluronan has strong water binding capacity…”
Get full text

Delayed graft function: Risk factors, consequences and parameters affecting outcome—results from MOST, A Multinational Observational Study by Lebranchu, Y., Halimi, J.M., Bock, A., Chapman, J., Dussol, B., Fritsche, L., Kliem, V., Oppenheimer, F., Pohanka, E., Salvadori, M., Soergel, M., Tufveson, G.

“…Delayed graft function (DGF) is a common complication after renal transplantation, and may affect graft function. The aim of this analysis was to evaluate risk…”
Get full text

Geographical prevalence, risk factors and impact of hepatitis B and C after renal transplantation by Kliem, V, Michel, U, Burg, M, Bock, A, Chapman, J, Dussol, B, Fritsche, L, Lebranchu, Y, Oppenheimer, F, Pohanka, E, Salvadori, M, Tufveson, G

“…Hepatitis B (HBV) and hepatitis C (HCV) virus infections are major risk factors affecting long-term morbidity and mortality after renal transplantation…”
Get more information